Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy.
Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy.
复制标题
DOI:
10.1002/ana.25243
复制
发表时间:
2018-06
影响因子:
11.2
通讯作者:
Heinzen EL
中科院分区:
文献类型:
--
作者:
Winawer MR;Griffin NG;Samanamud J;Baugh EH;Rathakrishnan D;Ramalingam S;Zagzag D;Schevon CA;Dugan P;Hegde M;Sheth SA;McKhann GM;Doyle WK;Grant GA;Porter BE;Mikati MA;Muh CR;Malone CD;Bergin AMR;Peters JM;McBrian DK;Pack AM;Akman CI;LaCoursiere CM;Keever KM;Madsen JR;Yang E;Lidov HGW;Shain C;Allen AS;Canoll PD;Crino PB;Poduri AH;Heinzen EL
Somatic variants are a recognized cause of epilepsy-associated focal malformations of cortical development (MCD). We hypothesized that somatic variants may underlie a wider range of focal epilepsy, including non-lesional focal epilepsy (NLFE). Through genetic analysis of brain tissue, we evaluated the role of somatic variation in focal epilepsy with and without MCD. We identified somatic variants through high-depth exome and ultra-high-depth candidate gene sequencing of DNA from epilepsy surgery specimens and leukocytes from 18 individuals with NLFE and 38 with focal MCD. We observed somatic variants in five cases in SLC35A2, a gene associated with glycosylation defects and rare X-linked epileptic encephalopathies. Nonsynonymous variants in SLC35A2 were detected in resected brain, and absent from leukocytes, in 3/18 individuals (17%) with NLFE, one female and two males, with variant allele frequencies (VAFs) in brain-derived DNA of 2–14%. Pathologic evaluation revealed focal cortical dysplasia type Ia (FCD1a) in two of the three NLFE cases. In the MCD cohort, nonsynonymous variants in SCL35A2 were detected in the brains of two males with intractable epilepsy, developmental delay, and MRI suggesting FCD, with VAFs of 19–53%; evidence for FCD was not observed in either brain tissue specimen. We report somatic variants in SLC35A2 as an explanation for a substantial fraction of NLFE, a largely unexplained condition, as well as focal MCD, previously shown to result from somatic mutation but until now only in PI3K-AKT-mTOR pathway genes. Collectively, our findings suggest a larger role than previously recognized for glycosylation defects in the intractable epilepsies.
登录
查看更多内容
影响因子:
30.8
作者:
Carvill, Gemma L.;Regan, Brigid M.;Yendle, Simone C.;O'Roak, Brian J.;Lozovaya, Natalia;Bruneau, Nadine;Burnashev, Nail;Khan, Adiba;Cook, Joseph;Geraghty, Eileen;Sadleir, Lynette G.;Turner, Samantha J.;Tsai, Meng-Han;Webster, Richard;Ouvrier, Robert;Damiano, John A.;Berkovic, Samuel F.;Shendure, Jay;Hildebrand, Michael S.;Szepetowski, Pierre;Scheffer, Ingrid E.;Mefford, Heather C.
通讯作者:
Mefford, Heather C.
影响因子:
9.8
作者:
Dazzo, Emanuela;Fanciulli, Manuela;Nobile, Carlo
通讯作者:
Nobile, Carlo
影响因子:
9.9
作者:
Hesdorffer, D. C.;Logroscino, G.;Hauser, W. A.
通讯作者:
Hauser, W. A.
影响因子:
14.9
作者:
Costello M;Pugh TJ;Fennell TJ;Stewart C;Lichtenstein L;Meldrim JC;Fostel JL;Friedrich DC;Perrin D;Dionne D;Kim S;Gabriel SB;Lander ES;Fisher S;Getz G
通讯作者:
Getz G
影响因子:
4.2
作者:
Doerre, K.;Olczak, M.;Marquardt, T.
通讯作者:
Marquardt, T.